Complete Genomics seals $45M for cheaper gene sequencing
Complete Genomics, provider of supposedly cheaper and faster DNA sequencing services, has raised $45 million in a fourth round of funding — a huge amount for a biotech company in today’s economic environment. Based in Mountain View, Calif., the company says it will be able to sequence people’s genes in only a few days, and for the bargain price of $5,000.
Apparently, genetic companies are where it’s at in the life science market right now. Earlier… Continue Reading
DFine stacks up $30M to mend spinal fractures
Healthcare developer DFine has brought in $30 million in fourth-round funding to commercialize a system to treat fractures in vertebrae caused by spine compression. Contributions came from BB&T Funds, Highland Capital Management, Prospect Venture Partners and Vanguard Ventures.
The San Jose, Calif. company has created an injection device, the StabiliT Vertebral Augmentation System, as well as human-safe StabiliT ER Bone Cement, to fill breaks. Osteoperosis, tumor growth and traumatic injury are the leading causes of the… Continue Reading